Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |